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doi:10.1016/j.ejvs.2011.06.043Abstract Objectives: To study contemporary treatment and outcome of abdominal aortic
aneurysm (AAA) repair in nine countries.
Design and methods: Data on primary AAA repairs 2005e2009 were amalgamated from national
and regional vascular registries in Australia, Denmark, Finland, Hungary, Italy, Norway,
Sweden, Switzerland and the UK. Primary outcome was in-hospital or 30-day mortality. Multi-
variate logistic regression was used to assess case-mix.
Results: 31,427 intact AAA repairs were identified, mean age 72.6 years (95% CI 72.5e72.7).
The rate of octogenarians and use of endovascular repair (EVAR) increased over time
(p < 0.001). EVAR varied between countries from 14.7% (Finland) to 56.0% (Australia). Overall
perioperative mortality after intact AAA repair was 2.8% (2.6e3.0) and was stable over time.
The perioperative mortality rate varied from 1.6% (1.3e1.8) in Italy to 4.1% (2.4e7.0) in
Finland. Increasing age, open repair and presence of comorbidities were associated with
outcome.
7040 ruptured AAA repairs were identified, mean age 73.8 (73.6e74.0). The overall perio-
perative mortality was 31.6% (30.6e32.8), and decreased over time (p Z 0.004).Department of Vascular Surgery, Guy’s and St Thomas NHS Foundation Trust, Westminster Bridge
i.uu.se (K. Mani).
ty for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
Treatment of Abdominal Aortic Aneurysm in Nine Countries 2005e2009 599Conclusions: The rate of AAA repair in octogenarians as well as EVAR increased over time. Peri-
operative outcome after intact AAA repair was stable over time, but improved after ruptured
repair. Geographical differences in treatment of AAA remain.
ª 2011 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Introduction
Over the past decade, results of several important rando-
mised controlled trials (RCTs) in treatment of abdominal
aortic aneurysms (AAA) have set the ground for dramatic
changes in management of this disease.1e5 Whilst rando-
mised clinical trials are essential for establishing the level I
evidence for bestmedical care provided to patients, analysis
of current clinical practice through national or regional
databases is a necessary complement to this evidence.
Analyses based on registry data have several advantages
compared to RCTs.6 They reflect every-day, often
population-based, practice and not just the practice of
centres of excellence. They can report on more than 90% of
the operated patients,7 compared to for instance only
approximately 20% of the patients that were randomised in
the centres participating in the EVAR1 Trial.1 The results
obtained from registries may therefore be more general-
isable than results from RCTs. Registry data also give a much
faster feedback and thus reflect contemporary as compared
to often historical data from the RCTs. Thus, such retro-
spective analyses of large datasets render a possibility to
understand how the results of randomised trials translate to
broader medical practice. In addition, audits of this kind can
serve as a basis for improvement through comparison.
In vascular surgery, there is a longstanding tradition of
registering and analysing results of surgical practice on
institutional, regional and national levels. International
comparisons of vascular surgical procedures and outcomes
have recently been presented through the vascular surgery
database reports published by the Vascunet collaboration on
behalf of the European Society of Vascular Surgery in 2007
and 2008.8,9 The first Vascunet report analysed indications
and patient selection for AAA treatment in five countries,
while the second report broadened the scope to also include
carotid reconstruction and outcome data. Despite discrep-
ancies in data definition and validity of national databases,
the reports indicated interesting differences between
countries in the treatment of AAA.
The current report, which focuses on AAA, is part of the
third analysis of the Vascunet database. Results of the
analysis of carotid reconstruction and lower limb revascu-
larization from the Vascunet database will be published
separately. The aim of the current analysis is to evaluate
indications, treatment strategies and outcome of AAA
treatment in nine countries over a contemporary period of
five years.Materials and Methods
Data on primary AAA repairs were amalgamated from nine
vascular registries for the period of 2005e2009, Table 1. The
registries operated on a national level in Denmark, Hungary,Italy, Norway, Sweden and the United Kingdom. The regis-
tries in Australia and Finland covered hospitals in a specific
geographical region, and the Swiss registry included AAA
repairs performed at University hospitals and large public
hospitals. An estimate of the percentage of AAA repairs
performed in each country/region that are included in each
registry as well as the presence or absence of internal and
external validation procedures for the registries are pre-
sented in Table 1. Data from the full five year period were
included from Australia, Denmark, Sweden and United
Kingdom, whilst Norway and Switzerland reported data for
2005e2008, Finland and Italy for 2007e2009 and Hungary for
2008e2009. Variables included patient demographics (age,
gender), comorbidities (heart, respiratory, and renal
disease, hypertension, diabetes, smoking), operative data
(date of operation, maximum diameter of the aneurysm,
intact or ruptured repair, open or endovascular repair) and
outcome data (30-day or in-hospital mortality).
The amalgamated data were analysed overall, per
country and per operation year to evaluate national differ-
ences in patient demographics, comorbidities, operative
data andoutcome.Due to thedifferences in theparticipating
registries, not all data were available from all countries, and
there were minor differences in the definitions of the vari-
ables. The properties of the participating registries and the
provided data are described in detail in Appendix 1. In-
hospital or 30-day mortality was used as primary outcome
depending on which data were provided in the separate
national or regional databases. Co-morbidity data were
based on the registered comorbidities as defined in the
original databases except for renal disease. For this param-
eter, five countries presented data on presence of renal
disease based on pre-set criteria that varied between regis-
tries (Appendix 1). Three countries reported the exact
preoperative creatinine level, and in those a creatinine level
>150 mmol/l was regarded as presence of renal disease.
To estimate the difference between in-hospital and 30-
day mortality, data from the Swedish Vascular Registry
(Swedvasc) 2000e2008 was analysed, as this registry
included data on hospitalisation dates on most, and date of
death for all AAA patients during this period. Date of death
is registered with 100% validity due to cross-matching with
the population registry. In-hospital as well as 30-day
mortality rates were calculated for 63% of AAA patients
registered in the Swedvasc registry over this period.
Statistical analysis
All continuous data are presented with mean and 95%
confidence intervals. Rates are presented as percentages
with 95% confidence intervals (CI). Time trends were ana-
lysed with the CochraneArmitage test. Multivariate logistic
regression models were used to estimate the odds ratios for
various factors in relation to 30-day or in-hospital mortality.
Table 1 Overview of the abdominal aortic aneurysm data included in the third VASCUNET analysis.
Coverage of
database
Rate of
AAA repairs
included
in databasea
Internal/external
validation
Years
included
Number of
cases, N
Intact, N Rupture, N Rupture repair
as rate of
total, % (95% CI)
Australia Regional
(State of
Victoria)
68% of AAA
repairs in State
of Victoria
Yes/Yes 2005e2009 2148 1814 334 15.5 (14.0; 17.2)
Denmark National 99% Yes/Yes 2005e2009 4238 2500 1026 29.1 (27.6; 30.6)
Finland Regional 100% of regional/
32% of national
AAA repairs
Yes/Yes 2007e2009 424 293 131 30.9 (26.5; 35.3)
Hungary National 55% No/Yes 2008e2009 311 269 42 13.5 (9.7; 17.3)
Italy National NA No/Yes 2007e2009 10101 9107 994 9.8 (9.3; 10.4)
Norway National 93% No/No 2005e2008 3272 2707 552 16.9 (15.6; 18.2)
Sweden National 93% Yes/Yes 2005e2009 5695 4134 1517 26.8(15.7; 28.0)
Switzerland University
and large
public hospitals
NA No/Yes 2005e2008 2183 1814 369 16.9 (15.3; 18.5)
United Kingdom National 29%b Yes/No 2005e2009 12476 8789 2075 19.1 (18.4; 19.8)
Total 2005e2009 40848 31427 7040 18.3 (17.9; 18.7)
CI Z Confidence interval.
a Rate of AAA repairs in the region/country that are registered in the VASCUNET database. Data from Australia, Denmark, Finland, Sweden and Hungary based on comparison of national/
regional databases and national in-patient registries.
b Comparison of all cases in Vascunet database to annual number of AAA repairs registered in the Hospital Episodes Statistics database 2009-10-01 to 2010-09-30. The rate increased from
9% in 2005 to 50% in 2009.
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comorbidities reported in all countries were included
(smoking status, cardiac disease and diabetes). When ana-
lysing the effect of treatment country on perioperative
mortality, each country was compared to the sum of all
other countries in the multivariate analysis. Cases with
lacking data were omitted. The models were tested for
goodness-of-fit and ability to predict outcome (Hos-
mereLemeshow statistic, C-statistic and Nagelkerkes
R-square). Statistical evaluation of data was carried out
using R Statistical Software Package (R Foundation for
Statistical Computing, Vienna, Austria) and SPSS version
18.0 for Mac (IBM Corporation, Somers, NY, USA).
Results
Overall, data on 40,848 primary AAA repairs were identified
(Table 1). On average, 18.3% (95% CI 17.9e18.7) of all AAA
repairs were performed for rupture. The rate of ruptured
AAA repair was higher in women, 21.4% (20.3e22.5),
compared to men, 17.8% (17.4e18.2). The rate of opera-
tions for ruptured AAA as a percentage of the total number
of AAA repairs varied from 9.8% (9.3e10.4) in Italy to 30.9%
(26.5e35.3) in Finland (Table 1).
Intact AAA repair
A total of 31,427 cases were registered as intact AAA
repairs. Patient characteristics overall and per country are
presented in Table 2. The mean age at the time of surgery
was 72.6 years (72.5e72.7), with a range of 68.3
(67.3e69.3) years in Hungary to 74.6 (74.2e74.9) years in
Australia (Table 2). Of all the intact AAA repairs, 13.3%
(12.9e13.7) were performed in women, and one fifth in
octogenarians. There was a slight but significant trend
towards increasing rate of octogenarians undergoing intact
AAA repair over time (Table 3). The use of endovascular
aneurysm repair (EVAR) varied between countries, from
14.7% (11.1e19.2) in Finland to 56.0% (53.7e58.2) in
Australia (Table 2). Overall, the rate of endovascular repair
increased over the study period (Table 3). The rates of
octogenarians and EVAR per country and year are presented
in Appendices 2 and 3. The rates of comorbidities and mean
aneurysm size at repair for the countries (where available)
are presented in Table 2. In Italy, only ranges of aneurysm
diameter were registered. Based on an analysis of these
data, 70.3% (69.4e71.2) of all intact AAA repairs in Italy
were performed in patients with a maximum aneurysm
diameter of >5 cm, as compared to 90.3% (89.5e91.0) in
the other countries reporting maximum aneurysm size.
The perioperative mortality rates, which were reported
as 30-day mortality in some countries and in-hospital
mortality in others, for all patients and subgroups are
presented in Table 4. Overall perioperative mortality after
intact AAA repair was 2.8% (2.6e3.0). Perioperative
mortality was higher in women compared to men, in octo-
genarians compared to younger patients and after open
repair compared to EVAR. Perioperative mortality was
higher for women compared to men after both EVAR and
open repair (EVAR: men 1.3% [1.1e1.5], women 2.4%
[1.7e3.3]; open repair: men 3.4% [3.1e3.7], women 4.5%[3.8e5.4]). Perioperative mortality after EVAR was one-
third of the mortality after open repair both for octoge-
narians and patients <80 years of age (EVAR: octogenarians
2.4% [2.0e3.0], <80 1.0% [0.8e1.2]; open repair: octoge-
narians 7.7% [6.7e8.9], <80 2.8% [2.6e3.1]). Overall, there
was no significant time trend in perioperative mortality
rates (Table 3). Perioperative mortality rates per country
and year are presented in Appendix 4. The perioperative
mortality decreased significantly over time in the United
Kingdom (Appendix 4).
In a multivariate logistic regression analysis, increasing
age, open repair and presence of comorbidities were all
associated with a significantly increased risk for perioper-
ative death, but gender was not (Table 5). Risk of peri-
operative death was increased in the United Kingdom when
compared to all other countries, and decreased in Italy and
Norway (Table 5). The goodness-of-fit tests showed
acceptable result with respect to the full model (Table 5).
The C-statistic (prediction power) of the models were in the
range of 0.70e0.71.
Ruptured AAA repair
A total of 7040 cases were registered as ruptured AAA
repairs. Patient characteristics overall and per country are
presented in Table 2. Mean patient age, the female to male
ratio and octogenarians, as well as mean aneurysm size
were higher in patients undergoing repair for ruptured AAA
compared to intact AAA repair. A higher rate of the patients
were current smokers and had documented renal disease
compared to those undergoing intact AAA repair. However,
the rate of cardiac disease, hypertension and diabetes was
lower. The rate of octogenarians undergoing ruptured AAA
repair increased over time, as well as the rate of EVAR for
ruptured AAA (Table 3). Rates of octogenarians and EVAR
per country and year are presented in Appendices 2 and 3.
The overall perioperative mortality after ruptured AAA
repair was 31.6% (30.6e32.8) (Table 4), and this decreased
over time, pZ 0.004 (Appendix 4). There was no significant
change in perioperative mortality over time after open
repair (mean 32.6%) or EVAR (mean 19.7%). Perioperative
mortalities per country and year are presented in Appendix
4. The perioperative mortality increased over time in
Norway and decreased in Sweden and the United Kingdom
(Appendix 4). As in intact AAA repair, old age, open repair
and presence of comorbidities were associated with peri-
operative death after ruptured AAA repair in a multivariate
logistic regression analysis (Table 5), but gender or smoking
were not. In this multivariate analysis, risk of perioperative
death was increased in Denmark and Switzerland when
compared to all other countries, and decreased in Italy and
Sweden (Table 5). The results of the goodness-of-fit tests
for the models are presented in Table 5. The C-statistic
(prediction power) of the models were in the range of
0.66e0.67.
30-Day and in-hospital mortality
In-hospital and 30-day mortality rates after AAA repair were
analysed in the Swedvasc registry 2000e2008. When ana-
lysing 6431 registered intact and ruptured AAA repairs, 718
Table 2 Patient characteristics in the VASCUNET database overall and per country. All rates presented as percentages. 95% confidence intervals presented in parenthesis.
Overall Australia Denmark Finland Hungary Italy Norway Sweden Switzerland United Kingdom
Intact
AAA
repair
Number of cases 31427 1814 2500 293 269 9107 2707 4134 1814 8789
Mean age, years 72.6
(72.5; 72.7)
74.6
(74.2; 74.9)
71.1
(70.8; 71.4)
71.1
(70.1; 72.1)
68.3
(67.3; 69.3)
72.6
(72.4; 72.7)
72.2
(71.9; 72.5)
72.1
(71.9; 72.3)
70.8
(70.3; 71.2)
73.6
(73.4; 73.7)
Rate women 13.3
(12.9; 13.7)
14.4
(12.9; 16.1)
17.2
(15.8; 18.7)
13.4
(9.9; 17.7)
15.6
(11.8; 20.4)
8.0
(7.5; 8.6)
17.8
(16.4; 19.3)
18.4
(17.2; 19.6)
11.1
(9.8; 12.7)
14.0
(13.3; 14.8)
Rate
octogenarians
19.2
(18.8; 19.7)
28.1
(26.1; 30.2)
12.2
(10.9; 13.5)
18.3
(14.3; 23.2)
7.1
(4.6; 10.8)
19.2
(18.4; 20.0)
18.8
(17.3; 20.3)
17.3
(16.2; 18.5)
16.2
(14.6; 18.0)
21.5
(20.6; 22.3)
Rate EVAR 43.9
(43.3; 44.4)
56.0
(53.7; 58.2)
23.8
(22.1; 25.5)
14.7
(11.1; 19.2)
17.5
(13.4; 22.5)
49.0
(48.0; 50.0)
29.0
(27.2; 30.9)
43.9
(42.3; 45.4)
37.4
(35.2; 39.7)
49.4
(48.3; 50.5)
Rate current
smokers
29.3
(28.8; 29.8)
14.9
(13.3; 16.6)
43.6
(41.7; 45.6)
38.5
(32.9; 44.6)
50.0
(37.3; 62.7)
22.7
(21.9; 23.6)
37.6
(35.8; 39.5)
37.1
(35.6; 38.7)
63.7
(61.4; 65.9)
20.1
(19.2; 21.0)
Rate cardiac
disease
49.2
(48.6; 49.8)
52.7
(50.4; 55.0)
39.6
(37.7; 41.5)
52.7
(47.0; 58.4)
58.9
(45.9; 70.8)
56.5
(55.5; 57.5)
49.1
(47.2; 51.0)
49.3
(47.8; 50.9)
42.3
(40.0; 44.6)
44.7
(43.7; 45.8)
Rate pulmonary
disease
23.7
(23.1; 24.3)
e 16.5
(15.1; 18.0)
21.3
(17.0; 26.4)
35.7
(24.5; 48.8)
27.7
(26.8; 28.6)
20.4
(18.9; 21.9)
22.5
(21.2; 23.9)
21.4
(19.6; 23.4)
e
Rate renal
disease
2.6
(2.4; 2.8)
28.2
(20.8; 37.0)
2.2
(1.7; 2.9)
0.7
(0.2; 2.5)
0.0
(0.0; 1.4)
0.1
(0.1; 0.2)
3.0
(2.4; 3.7)
2.9
(2.3; 3.6)
5.9
(4.9; 7.1)
8.3
(7.3; 9.5)
Rate
hypertension
73.5
(72.9; 74.1)
79.1
(77.2; 81.0)
62.9
(61.0; 64.8)
67.9
(62.4; 73.0)
91.1
(80.7; 96.1)
82.8
(82.0; 83.6)
50.3
(48.4; 52.2)
72.1
(70.7; 73.5)
73.8
(71.7; 75.8)
e
Rate diabetes 11.8
(11.5; 12.2)
15.4
(13.8; 17.2)
9.1
(8.1; 10.3)
15.4
(11.7; 20.0)
16.1
(8.7; 27.8)
13.0
(12.3; 13.7)
8.9
(7.9; 10.1)
11.3
(10.3; 12.3)
12.4
(11.0; 14.0)
11.5
(10.8; 12.2)
Mean AAA
diameter, cm
6.7
(6.6; 6.7)
6.5
(6.3; 6.7)
e 6.4
(6.2; 6.7)
6.2
(6.1; 6.4)
e 6.5
(6.4; 6.5)
6.4
(6.3; 6.6)
e 7.1
(7.0; 7.2)
Ruptured
AAA
repair
Number
of cases
7040 334 1026 131 42 994 552 1517 369 2075
Mean age,
years
73.8
(73.6; 74.0)
75.4
(74.5; 76.3)
72.4
(72.0; 72.9)
73.1
(71.5; 74.7)
71.9
(68.6; 75.1)
74.7
(74.1; 75.2)
72.3
(71.6; 72.9)
73.8
(73.4; 74.2)
73.2
(72.3; 74.2)
74.3
(74.0; 74.7)
Rate women 16.2
(15.3; 17.1)
16.2
(12.6; 20.5)
13.3
(11.3; 15.5)
13.0
(8.3; 19.8)
23.8
(13.5; 38.5)
14.5
(12.4; 16.8)
17.9
(15.0; 21.4)
19.6
(17.7; 21.7)
12.2
(9.2; 15.9)
16.2
(14.7; 17.8)
Rate
octogenarians
27.0
(26.0; 28.1)
34.2
(29.3; 39.5)
20.6
(18.2; 23.1)
32.1
(24.7; 40.5)
23.8
(13.5; 38.5)
33.9
(31.1; 36.9)
19.9
(16.8; 23.5)
26.9
(24.7; 29.2)
27.4
(23.1; 32.2)
27.5
(25.6; 29.5)
Rate EVAR 11.7
(10.9; 12.5)
9.3
(6.6; 12.9)
0.6
(0.3; 1.3)
0.0
(0.0; 2.8)
4.8
(1.3; 15.8)
16.9
(14.7; 19.4)
7.6
(5.4; 10.5)
15.2
(13.4; 17.1)
20.9
(17.0; 25.3)
12.7
(11.2; 14.3)
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Treatment of Abdominal Aortic Aneurysm in Nine Countries 2005e2009 603deaths were registered as in-hospital deaths, out of which 40
occurred more than 30-days after the AAA repair. In total 95
deaths occurred after discharge from the operating hospital
but within 30-days from the AAA repair. The overall in-
hospital mortality rate was 11.2% (10.4e12.0), while the 30-
day mortality rate was 11.8% (11.1e12.6). Among patients
undergoing intact AAA repair the mortality increased from
2.6 (2.2e3.1) to 3.0% (2.5e3.6), and among patients under-
going ruptured AAA repair the mortality increased from 30.8
(28.8e32.9) to 32.1% (30.1e34.3), when in-hospital and 30-
day mortality rates were compared.Discussion
The Vascunet collaboration makes it possible to amal-
gamate vascular surgical data across several regions,
resulting in large cohorts and enabling geographical
comparisons to be made. This current report represents the
analysis of the largest international cohort of patients
operated on for AAA ever presented. The report confirms
ongoing changes in management of AAA disease in Europe
and Australia over the past five years, with stable peri-
operative mortality after intact AAA repair and improved
outcome after ruptured repair. In addition, the geograph-
ical comparison sheds light on differences in patient
selection, operative technique and outcome.
Naturally, there are several important limitations asso-
ciated with the amalgamation of large cohorts of data from
different countries. As described in Table 1, while some
data included in the Vascunet analysis have national
coverage and include almost all AAA repairs performed in
the participating country over the past years, others
represent regions or specific hospitals of the participating
country, introducing a risk of selection bias. The procedures
to assess internal and external validity of data vary
between countries. Not all databases could contribute with
data for the full 5-year period studied, introducing a risk of
bias. To address this, per year analyses for each country are
presented in the provided appendices. The definitions and
registrations of co-morbidity data vary somewhat, making
comparisons of rates of comorbidities complex. There has
been a trend, however, towards common definitions,
a process that has been facilitated by yearly meetings
within the Vascunet collaboration since 1997. The Vascunet
group has now defined a data dictionary with specifications
for each datafield and each country is moving towards
these internationally agreed definitions.
This report is based on retrospective analysis of
prospectively gathered data on AAA patients, and thus
reflects the current clinical practice where patients are
selected to a specific treatment based on clinical features
and not randomisation. Thus, comparison of outcomes
between different registries based on treatment modality
should be interpreted with these limitations in mind.
Additionally, the registered outcome endpoint of peri-
operative mortality varies between countries, with 30-day
mortality being registered in some and in-hospital deaths in
others. Based on analysis of the Swedvasc registry, although
the 30-day mortality rate was slightly higher, there was no
significant difference in 30-day and in-hospital mortality
rate after AAA repair. In practice, in-hospital mortality rate
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604 K. Mani et al.includes cases with fatal outcome after a long period of
hospitalisation, while these would typically not be included
in the 30-day mortality. On the other hand, 30-day
mortality rate includes cases with fatal outcome within
30-days after AAA repair even if the deaths occur after
discharge from the primary hospital. Despite these limita-
tions, however, these data represent what is happening in
current practice and it is reasonable to assume that certain
core variables such as patient age, gender, operative
technique, aneurysm type (intact or ruptured) as well as
country and operative year can be reliably compared
between countries. The current report focuses on pre-
senting developments and trends in intact and ruptured
AAA repair in a large, multinational database over a recent
period of time. The time period was chosen to reflect
current trends and enable adequate comparisons between
registries.
Interestingly, the current report indicates a large
geographical difference in rate of ruptured AAA repair as
a percentage of all AAA repairs (Table 2). While only one in
ten of AAA repairs are performed for rupture in Italy,
almost one-third of all AAA repairs in Finland and Denmark
and one quarter of repairs in Sweden are for rupture. These
large differences are not explained by potential differences
in reporting or database coverage. Factors which affect the
rate of repairs for ruptured AAA include diagnostic activity
such as screening, patient selection (e.g. diameter limit for
treatment, repair on elderly/diseased patients) and
rupture rate. One would have suspected that the propor-
tion of patients treated for ruptured AAA would have been
lower in scarcely populated countries, but the figures
suggest the opposite, indicating that wider indications for
elective repair is a more reasonable explanation for low
proportions of ruptured AAA repair. The high rate of elec-
tive repairs in Italy could be partly explained by the higher
rate of small aneurysms (5 cm) being repaired compared
to other countries.
Several other factors indicate clear differences in
patient selection for AAA repair between countries
(Table 2). The proportion of females undergoing AAA repair
varies from 8% in Italy to 18% in Sweden. The mean age and
rate of octogenarians undergoing AAA repair also vary. More
than one quarter of all intact AAA repairs in Australia were
performed in octogenarians, as compared to less than one
tenth in Hungary. The rate of EVAR was also consistently
the highest in Australia throughout the study period
(Appendix 3). This could be explained by the higher rate of
octogenarians being offered endovascular repair.
The rapid and extensive implementation of EVAR for AAA
repair following the positive results of the large randomised
trials1,2 is clearly demonstrated in the current analysis,
where the rate of EVAR increased in all countries over time,
and reached >50% of all intact AAA repairs in Australia,
Italy, Sweden and the United Kingdom in 2009. EVAR for
ruptured AAA repair however has not yet been widely
adopted, although the rates are increasing over time. The
4.2% improvement in perioperative mortality after ruptured
AAA repair over the studied time period could be attribut-
able to the increased use of EVAR for ruptures, as the
perioperative mortality for each technique was stable over
time but the rate of EVAR for rupture increased by 10%. The
perioperative mortality after EVAR for ruptured AAA was on
Table 4 Rate of perioperative mortality in the VASCUNET database overall and per country. All values are percentages th 95% confidence intervals.
Overall Australiaa Denmarkb Finlandb Hungarya Italyb Norwaya Swedenb Switzerlanda United Kingdoma
Intact
AAA repair
Overall 2.8
(2.6; 3.0)
2.4
(1.8; 3.2)
3.3
(2.7; 4.1)
4.1
(2.4; 7.0)
2.6
(1.3; 5.3)
1.6
(1.3; 1.8)
2.5
(1.9; 3.1
2.6
(2.2; 3.2)
3.2
(2.4; 4.4)
4.0
(3.6; 4.4)
Men 2.6
(2.4; 2.8)
2.1
(1.5; 3.0)
3.4
(2.7; 4.3)
4.7
(2.7; 8.1)
3.1
(1.5; 6.2)
1.5
(1.3; 1.8)
2.4
(1.8; 3.1
2.3
(1.9; 2.9)
3.2
(2.3; 4.5)
3.6
(3.2; 4.0)
Women 4.0
(3.4; 4.6)
3.8
(2.1; 6.9)
2.6
(1.4; 4.5)
0 0 1.9
(1.1; 3.2)
2.9
(1.7; 4.8
3.9
(2.8; 5.6)
3.0
(1.2; 7.5)
6.5
(5.2; 8.0)
<80 years 2.3
(2.1; 2.4)
1.4
(0.9; 2.2)
2.7
(2.1; 3.5)
3.0
(1.4; 6.0)
2.8
(1.4; 5.7)
1.4
(1.1; 1.7)
2.3
(1.7; 3.0
2.3
(1.8; 2.8)
3.0
(2.1; 4.2)
3.0
(2.7; 3.5)
Octogenarians 4.9
(4.4; 5.5)
4.9
(3.4; 7.2)
7.2
(4.8; 10.7)
9.4
(4.1; 20.3)
0 2.4
(1.8; 3.2)
3.2
(2.0; 5.1
4.3
(3.1; 6.1)
4.6
(2.5; 8.6)
7.5
(6.4; 8.8)
OR 3.5
(3.3; 3.8)
3.8
(2.6; 5.3)
4.0
(3.2; 4.9)
4.4
(2.5; 7.7)
2.3
(1.0; 5.2)
2.2
(1.9; 2.7)
2.7
(2.0; 3.6
3.2
(2.6; 4.0)
3.6
(2.5; 5.2)
5.3
(4.6; 6.0)
EVAR 1.4
(1.2; 1.6)
1.3
(0.8; 2.2)
1.2
(0.6; 2.4)
2.3
(0.4; 12.1)
4.3
(1.2; 14.2)
0.9
(0.6; 1.2)
0.3
(0.1; 1.1
1.9
(1.3; 2.6)
2.6
(1.5; 4.4)
1.8
(1.5; 2.3)
Ruptured
AAA repair
Overall 31.6
(30.6; 32.8)
32.0
(27.3; 37.2)
35.4
(32.5; 38.4)
29.0
(21.9; 37.3)
38.1
(25.0; 53.2)
27.4
(24.7; 30.2)
28.6
(24.9; 32 )
28.3
(26.1; 30.7)
39.2
(33.4; 45.4)
34.2
(32.2; 36.2)
Men 30.7
(29.6; 32.0)
28.2
(23.3; 33.8)
34.9
(31.8; 38.1)
29.8
(22.2; 38.8)
37.5
(22.9; 54.7)
26.6
(23.7; 29.7)
29.9
(25.9; 34 )
26.7
(24.3; 29.2)
38.2
(32.0; 44.9)
33.2 (31.0; 35.4)
Women 36.2
(33.5; 39.1)
51.9
(38.9; 64.6)
38.8
(31.0; 47.3)
23.5
(9.6; 47.3)
40.0
(16.8; 68.7)
31.9
(24.9; 39.9)
22.4
(15.3; 31 )
35.2
(30.0; 40.8)
45.5
(29.8; 62.0)
39.0
(33.9; 44.3)
<80 years 27.1
(25.9; 28.4)
25.1
(19.8; 31.3)
29.7
(26.6; 32.9)
22.5
(15.0; 32.2)
34.4
(20.4; 51.7)
22.3
(19.2; 25.6)
28.3
(24.3; 32 )
23.1
(20.7; 25.7)
34.7
(28.0; 41.9)
30.0
(27.8; 32.4)
Octogenarians 43.6
(41.4; 45.9)
44.7
(35.9; 53.9)
57.1
(50.4; 63.6)
42.9
(29.1; 57.8)
50.0
(23.7; 76.3)
37.4
(32.4; 42.7)
29.6
(21.8; 38 )
42.8
(38.0; 47.6)
50.7
(39.5; 61.8)
44.5
(40.5; 48.6)
OR 32.6
(31.4; 33.9)
33.0
(28.0; 38.5)
35.4
(32.5; 38.4)
29.0
(21.9; 37.3)
37.5
(24.2; 53.0)
28.9
(25.9; 32.1)
29.0
(24.7; 33 )
30.1
(27.6; 32.6)
44.6
(37.7; 51.6)
34.6
(32.2; 37.0)
EVAR 19.7
(17.0; 22.7)
22.6
(11.4; 39.8)
33.3
(9.7; 70.0)
e 50.0
(9.5; 90.5)
19.6
(14.3; 26.3)
12.5
(5.0; 28.
18.7
(14.2; 24.2)
21.1
(12.5; 33.3)
20.4
(15.6; 26.2)
OR Z Open repair; EVAR Z Endovascular aneurysm repair.
a In-hospital mortality.
b 30-day mortality.
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Table 5 Multivariate analysis of odds ratio for perioperative death after AAA repair.
Odds Ratio 95% Confidence
interval
P-value Hosmere
Lemeshow
R-square
Intact AAA repair Age per year 1.081 (1.068; 1.094) <0.001 0.304 7.3%
Female gender 1.156 (0.942; 1.419) 0.166
Open repair 3.311 (2.747; 3.968) <0.001
Current smoker 1.223 (1.021; 1.465) 0.029
Cardiac disease 1.445 (1.233; 1.692) <0.001
Diabetes 1.424 (1.146; 1.770) 0.001
Australia 0.937 (0.680; 1.291) 0.690 0.054 6.0%
Denmark 1.228 (0.959; 1.572) 0.103 0.055 6.1%
Finland 1.391 (0.752; 2.575) 0.293 0.057 6.0%
Hungary 1.321 (0.315; 5.538) 0.703 0.031 6.0%
Italy 0.559 (0.463; 0.676) <0.001 0.012 6.7%
Norway 0.626 (0.460; 0.853) 0.003 0.004 6.2%
Sweden 1.038 (0.826; 1.304) 0.750 0.028 6.0%
Switzerland 1.372 (0.980; 1.922) 0.066 0.017 6.1%
United Kingdom 1.699 (1.441; 2.004) <0.001 0.004 6.7%
Ruptured AAA repair Age per year 1.062 (1.053; 1.071) <0.001 0.412 9.5%
Female gender 1.055 (0.895; 1.243) 0.522
Open repair 2.183 (1.761; 2.717) <0.001
Current smoker 1.104 (0.962; 1.266) 0.158
Cardiac disease 1.461 (1.287; 1.659) <0.001
Diabetes 1.328 (1.092; 1.616) 0.005
Australia 1.001 (0.773; 1.296) 0.996 0.160 8.3%
Denmark 1.290 (1.088; 1.528) 0.003 0.339 8.5%
Finland 0.812 (0.480; 1.375) 0.439 0.363 8.3%
Hungary 0.834 (0.086; 8.114) 0.876 0.134 8.3%
Italy 0.765 (0.649; 0.901) 0.001 0.265 8.6%
Norway 0.951 (0.756; 1.197) 0.670 0.214 8.3%
Sweden 0.759 (0.645; 0.893) 0.001 0.398 8.6%
Switzerland 1.830 (1.390; 2.409) <0.001 0.098 8.8%
United Kingdom 1.137 (0.991; 1.304) 0.067 0.111 8.4%
606 K. Mani et al.average 12.9% better than after open repair. In the multi-
variate analysis, open repair was associated with an odds
ratio of 2.2 for perioperative mortality after ruptured AAA
repair. The current analysis however does not take into
account anatomical variations or differences in patient
symptoms and circulatory stability after rupture. These
factors would affect choice of operative technique as well
as outcome, and are likely to be important confounders.
The current study confirms the result of previous reports
showing higher perioperative mortality in women and
octogenarians as well as after open repair in a univariate
analysis.10e12 However, female gender was not a significant
risk factor for perioperative death in a multivariate anal-
ysis. The higher age among female patients could explain
the higher mortality in this group in the univariate analysis.
Importantly, the database does not include any data on the
anatomical suitability of the aneurysm for open or endo-
vascular repair. Thus, the difference in outcome after open
and endovascular repair is difficult to assess, as this could
be partly due to case selection, a higher rate of complex
aneurysms being treated with open surgery.
The perioperative mortality rates after intact and
ruptured AAA repair in the different countries were more
homogenous in the current report than in the previous
Vascunet report.9 The perioperative mortality after intactAAA repair in the United Kingdom has markedly decreased
in the current report (4.0%) compared to the previous
report (7.9%).9 This could indicate early success for the AAA
quality improvement programme, which was initiated by
the Vascular Society of Great Britain and Ireland in order to
improve perioperative outcome after the publication of the
second Vascunet report.9 The multivariate analysis, taking
some (but not all) important potential confounders related
to case-mix into consideration, still indicates a higher risk
of perioperative death after intact AAA repair in the UK and
a lower risk in Italy and Norway. It should be noted,
however, that there has been no external validation of AAA
registration in the latter two countries (Table 1). Addi-
tionally, although exact aneurysm size data were not
available for all countries, the data suggest that a higher
rate of small aneurysms (5 cm) are treated with elective
repair in Italy than in other countries. This could have
a positive impact on the perioperative outcome in Italy.
Interestingly, the patients treated in the UK had the highest
reported mean aneurysm diameter, possibly a result of the
fact that many centres participated in the UK Small Aneu-
rysm Trial,13 indicating differences in patient selection that
would affect outcome. Patients in the UK also had the
highest rate of renal disease, which would affect peri-
operative outcome negatively.
Treatment of Abdominal Aortic Aneurysm in Nine Countries 2005e2009 607Conclusions
In an analysis of AAA repair in nine countries, the rate of AAA
repair in octogenarians as well as the use of endovascular
techniques has increased over the past five years with stable
perioperative outcome after intact AAA repair and improved
outcome after ruptured repair. EVAR is associated with
a lower perioperative mortality than open repair, and
patients over the age of 80 undergoing open repair havemore
thandouble themortality riskof thoseundergoingeitheropen
repair below the age of 80 or EVAR at any age. Although the
perioperative mortality after AAA repair is more homogenous
between countries than in the previous Vascunet report,
there are still national differences both in perioperative
outcome and in patient selection that merit further studies.
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